Skip to content

Verification study of the new peripheral intravenous catheter

Verification study of the new peripheral intravenous catheter for reducing catheter failure incidence: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032210224
Enrollment
60
Registered
2021-08-06
Start date
2021-08-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases which are needed administration of stimulating drugs

Interventions

Randomization of catheterization using new unapproved peripheral intravenous catheter at the upper arm vein with using a short peripheral intravenous catheter at the forearm vein

Sponsors

Mineo Kurokawa
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients must satisfy the followings; . 1) Patients are scheduled to administrate stimulant drugs using peripheral intravenous catheter. 2) Over 19 years, regardless of gender 3) Patients are scheduled to continuous infusion therapy over 24 hours 4) Patients give us their written consent for the study 5) The first catheterization at this hospitalization

Exclusion criteria

Exclusion criteria: The following patients must be excluded. 1) Patients are unable to maintain the position to fully rotate the shoulder joint and rotate the elbow joint 2) Having skin disorders at the puncture site 3) Having peripheral neuropathy 4) Having a history of vasovagal reflex due to puncture 5) Having a history of thrombosis 6) With end-stage renal disease (stage 2 or higher) 7) Having abnormal blood coagulation or bleeding tendency (PT-INR 1.5 or more, APTT 36.1 seconds or more, while taking any anticoagulant or antiplatelet drugs) 8) Patient is planned of highly invasive tests (endoscopy, bronchoscopy) 9) Participation of this study is judged inappropriate for patient by physician

Design outcomes

Primary

MeasureTime frame
The incidence rate of catheter failures (%)

Secondary

MeasureTime frame
1) The incidence rate of catheter failures per 1000 days 2) Presence or absence of a thrombus in the vessel and a subcutaneous edema 3) Signs and symptoms such as redness, swelling, induration and occulusion 4) Subjective evaluation of catheter placement

Contacts

Public ContactMurayama Ryoko

Fujita Health University

ryoko.murayama@fujita-hu.ac.jp+81-562-93-9446

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026